Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain

Pain - Tập 93 - Trang 207-212 - 2001
Peter J Cabot1,2,3, Laurenda Carter1,2, Michael Schäfer1,2,4, Christoph Stein1,2,4
1Behavioral Pharmacology and Genetics Section, Intramural Research Program, NIDA/NIH, Baltimore, MD 21224, USA
2Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University, Baltimore, MD 21287-8711, USA
3School of Pharmacy, The University of Queensland, St Lucia, Queensland, Australia 4072
4Klinik für Anaesthesiologie und Operative Intensivmedizin, Klinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, D12200 Berlin, Germany

Tài liệu tham khảo

Barber, 1994, A pharmacological profile of the novel, peripherally-selective kappa- opioid receptor agonist, EMD 61753., Br J Pharmacol, 113, 1317, 10.1111/j.1476-5381.1994.tb17142.x Coggeshall, 1997, Opioid receptors on peripheral sensory axons., Brain Res, 764, 126, 10.1016/S0006-8993(97)00446-0 Hassan, 1992, Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat., Neurosci Lett, 140, 85, 10.1016/0304-3940(92)90688-4 Hiddinga, 1994, Enkephalin-containing peptides processed from proenkephalin significantly enhance the antibody-forming cell responses to antigens., J Immunol, 152, 3748, 10.4049/jimmunol.152.8.3748 Linner, 1996, Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes., Endocrinology, 137, 857, 10.1210/endo.137.3.8603595 Machelska, 1998, Pain control in inflammation governed by selectins., Nat Med, 4, 1425, 10.1038/4017 Machelska, 1999, Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans., J Pharmacol Exp Ther, 290, 354 Prezwlocki, 1992, Stein. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception., Neuroscience, 48, 491, 10.1016/0306-4522(92)90509-Z Schafer, 1994, Interleukin 1 and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue., Proc Natl Acad Sci USA, 91, 4219, 10.1073/pnas.91.10.4219 Sharp, 1997, Pain killers of the immune system., Nat Med, 3, 831, 10.1038/nm0897-831 Stein, 1995, The control of pain in peripheral tissue by opioids., N Engl J Med, 332, 1685, 10.1056/NEJM199506223322506 Stein, 1988, Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds., Pharmacol Biochem Behav, 31, 451, 10.1016/0091-3057(88)90372-3 Stein, 1989, Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors., J Pharmacol Exp Ther, 248, 1269 Stein, 1990, Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation., Proc Natl Acad Sci USA, 87, 5935, 10.1073/pnas.87.15.5935 Stein, 1990, Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin., J Neurosci, 10, 1292, 10.1523/JNEUROSCI.10-04-01292.1990 Stein, 1997, Peripheral opioid analgesia., Pain Rev, 4, 171